0001816722-21-000001.txt : 20211015 0001816722-21-000001.hdr.sgml : 20211015 20211015151059 ACCESSION NUMBER: 0001816722-21-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20211015 DATE AS OF CHANGE: 20211015 EFFECTIVENESS DATE: 20211015 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Ansa Biotechnologies, Inc. CENTRAL INDEX KEY: 0001816722 IRS NUMBER: 830744780 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-417198 FILM NUMBER: 211325857 BUSINESS ADDRESS: STREET 1: 626 BANCROFT WAY STREET 2: SUITE A CITY: BERKELEY STATE: CA ZIP: 94710 BUSINESS PHONE: (248) 227-5556 MAIL ADDRESS: STREET 1: 626 BANCROFT WAY STREET 2: SUITE A CITY: BERKELEY STATE: CA ZIP: 94710 D 1 primary_doc.xml X0708 D LIVE 0001816722 Ansa Biotechnologies, Inc. 1198 65th Street #250 Emeryville CA CALIFORNIA 94608 (248) 227-5556 DELAWARE None None Corporation true 2018 Daniel Lin-Arlow c/o Ansa Biotechnologies, Inc. 1198 65th Street #250 Emeryville CA CALIFORNIA 94608 Executive Officer Director Sebastian Palluk c/o Ansa Biotechnologies, Inc. 1198 65th Street #250 Emeryville CA CALIFORNIA 94608 Executive Officer Director Biotechnology Decline to Disclose 06b false 2021-10-08 false true true false 0 5000000 5000000 0 false 7 0 0 0 false Ansa Biotechnologies, Inc. /s/ Daniel Lin-Arlow Daniel Lin-Arlow Chief Executive Officer 2021-10-15